Proteome-wide Profiling of Asymmetric Dimethylated Arginine in Human Breast Tumors.
Ontology highlight
ABSTRACT: Arginine methylation catalyzed by protein arginine methyltransferases (PRMTs) is a prevalent post-translational modification (PTM) that regulates diverse cellular processes. Aberrant expression of type I PRMTs that catalyze asymmetric arginine dimethylation (ADMA) is often found in cancer, though little is known about the ADMA status of substrate proteins in tumors. Using LC-MS/MS along with pan-specific ADMA antibodies, we performed global mapping of ADMA in five patient-derived xenograft (PDX) tumors representing different subtypes of human breast cancer. In total, 403 methylated sites from 213 proteins were identified, including 322 novel sites when compared to the PhosphositesPlus database. Moreover, using peptide arrays in vitro, approximately 70% of the putative substrates wer
SUBMITTER: Ma M
PROVIDER: S-EPMC10726702 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA